RENEE SONS: Open Payments
NPI 1548783400 · KAPLAN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 16 payments from 8 companies in 2025. Trend: 2023 $314 · 2024 $230 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| ABBVIE INC. | 2 | $42 |
| Astellas Pharma US Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: Rybelsus, VIBERZI, AIRSUPRA, GARDASIL 9, Ozempic, Veozah, REXULTI, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
